A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Name: A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
Published: 2012
License: Public Domain

Abbott · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

dyslipidemia

dyslipidemia, fibrates, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents